Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies

Blood (2022) 140 (20): 2113–2126.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals